TrialJournal for immunotherapy of cancer2025

Carboplatin, etoposide, atezolizumab, and bevacizumab in the first-line treatment of patients with extensive stage small-cell lung cancer: the GOIRC-01-2019 CeLEBrATE study.

Giuseppe Lamberti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.